Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Survey Shows Outlook Worsening for Nearly 100 Million People With the Most Challenging Form of Hypertension


News provided by

Medtronic Inc.

29 Nov, 2011, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, November 29, 2011 /PRNewswire/ --

- UK PATIENTS DEMAND NEW TREATMENT OPTIONS -

- Hypertension Experts Launch New Global Awareness Effort 'Power Over Pressure'  to Support and Educate Patients

Despite ongoing medical care, an alarming majority (57 percent) of people in the UK with 'treatment-resistant' hypertension reported in a new survey that high blood pressure remains their most serious health concern. Nearly three out of four patients (72 percent) of respondents said they need new treatment options to get their dangerously high blood pressure under control.

To view the multimedia assets associated with this release, please click:
http://www.multivu.com/mnr/53359-hypertension-global-awareness-effort-power-over-pressure-educate-patients

Treatment-resistant hypertension, defined as persistently high blood pressure despite treatment with three or more medications from different classes, poses a serious health threat to nearly 100 million people worldwide.[1,2]

The survey was conducted by Harris Interactive with more than 4,500 high blood pressure patients worldwide as the first step in a global health campaign called Power Over Pressure, which is endorsed by both the European Society of Hypertension (ESH) and the American Society of Hypertension, Inc. (ASH). In Europe, 2,622 people participated in the survey, of which 538 were from the UK. Power Over Pressure is designed to educate and empower patients and physicians to finally take control of this challenging disease - visit http://www.poweroverpressure.com.

The survey, supported by Medtronic, also found that people in the UK with treatment-resistant hypertension are extremely worried about their overall health. Two thirds (65 percent) of respondents described their overall health as 'fair or poor', despite the fact that most people in the UK with treatment-resistant hypertension reported being under the care of either a general practitioner (71 percent) or a cardiologist (14 percent).  

"A new approach is needed to improve control of this most challenging form of hypertension," said Professor Roland Schmieder, co-chair of the Power over Pressure campaign and professor of internal medicine, nephrology and hypertension, and head of the clinical research centre for hypertension and vascular medicine at the department of nephrology and hypertension, University Hospital Erlangen, Germany. "The number of treatment-resistant patients has increased by 62 percent in the past 20 years.  Our survey results underscore the impact that treatment-resistant hypertension has on our patients and the critical need for more collaboration between patients and their physicians as well as appropriate referrals to specialists to aid in the management of this disease."

Dr. Charles Knight, consultant interventional cardiologist and clinical director of cardiovascular services, Barts and the London NHS Trust, London, UK, added: "Hypertension is a growing problem in the UK and treatment-resistant hypertension is something we need to urgently address. The results from this survey show that, not only does it affect people's physical health, but also their mood and quality of life. It is vital that we improve outcomes for these patients using new treatment options."  

The survey revealed that adults with treatment-resistant hypertension face more serious medical challenges compared to others with less advanced forms of the disease. They are more likely to suffer from other life threatening illnesses including type 2 diabetes (33 percent for treatment-resistant patient vs. 11 percent for uncontrolled patients), heart disease (25 percent vs. 8 percent) and obesity (24 percent vs. 17 percent); they take an average of four pills each day for their prescribed blood pressure medications and many have been struggling to control their high blood pressure for more than 10 years.

Patients from the UK with treatment-resistant hypertension in the survey indicated that the condition is their most serious health concern and has a profound impact on their everyday lives.  A majority of patients (58 percent) admitted to being very worried about having a stroke as a result of their high blood pressure. Three out of four patients with treatment-resistant hypertension say their high blood pressure has had a negative impact on their overall peace of mind (75 percent) and overall health (80 percent).  

In addition, patients with treatment-resistant hypertension want more options to manage their condition. Nearly three out of four patients (73 percent) with treatment-resistant hypertension expressed concern about the number of medications they are taking, and more than three out of four patients (77 percent) said they wish it was easier to get their blood pressure under control.  Additionally, two out of three patients with treatment-resistant hypertension (66 percent) predicted that their quality of life would greatly improve if they could control their blood pressure with fewer medications.

About Power Over Pressure

A team of global hypertension experts has reviewed the findings of this global survey. In response, the group is launching Power Over Pressure to raise awareness of the challenges faced by the nearly 100 million people worldwide who are living with treatment-resistant hypertension. The campaign aims to educate and empower patients and physicians finally to take control of this challenging disease.  More information about the campaign is available online at http://www.poweroverpressure.com.

Power Over Pressure is chaired by two world-renowned hypertension experts: Roland E. Schmieder, M.D., professor of internal medicine, nephrology and hypertension and head of the clinical research centre for hypertension and vascular medicine at the department of nephrology and hypertension of the University Hospital Erlangen, in Germany; and Suzanne Oparil, M.D., professor of medicine, physiology and biophysics, and director of the vascular biology and hypertension program in the division of cardiovascular disease at the University of Alabama at Birmingham, in the United States.

About Treatment-Resistant Hypertension

Treatment-resistant hypertension is an especially dangerous chronic disease because of its association with increased cardiovascular risk, including stroke and heart attack, as well as heart failure and kidney disease. Research suggests that 28 percent of treated hypertensive individuals are considered resistant to treatment.[3]  Additionally, these patients have a threefold increase in risk of cardiovascular events compared to individuals with controlled high blood pressure. [4]

About the Survey

The survey polled a range of 400 to 800 people with uncontrolled hypertension in each of eight countries around the world: Brazil, France, Germany, Italy, Japan, Spain, United Kingdom and United States.  In each country, at least 200 adults with treatment-resistant hypertension taking three or more medications and at least 200 adults with uncontrolled hypertension taking one, two or no medications were interviewed.  

This survey was conducted online October 4 - 25, 2011 by Harris Interactive and sponsored by Medtronic among 4,574 adults aged 18+ who self-report that they have been diagnosed with uncontrolled (n=2,649) or resistant (n=1,925) hypertension within the United States (n=571 uncontrolled, n=238 resistant), United Kingdom (n=220 uncontrolled, n=318 resistant), France (n=214 uncontrolled, n=210 resistant), Germany (n=291 uncontrolled, n=218 resistant), Italy (n=393 uncontrolled, n=221 resistant), Spain (n=280 uncontrolled, n=257 resistant), Brazil (n=376 uncontrolled, n=213 resistant), and Japan (n=304 uncontrolled, n=250 resistant).

References

1. Persell S. D. Prevalence of Resistant Hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076-1080.

2. "Hypertension and cardiovascular disease", World Heart Federation 2011, http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/hypertension/. Accessed 28 Oct 2011.

3. Egan B. M., et al. Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988-2008. Circulation. 2011;124(9):1046-1058.

4. Doumas M., et al. Benefits from Treatment and Control of Patients with Resistant Hypertension. International Journal of Hypertension. 2011. DOI 10.4061/2011/318549.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.